X Bioscience Public Company Limited
X Bioscience Public Company Limited, together with its subsidiaries, sells food and beverages in Thailand. It engages in the food and beverages investment and restaurant businesses. The company also manufactures and sells biological products; and generates and transmits electric power. Its brands include Kagonoya, Le Boeuf, and Bake Cheese Tart. The company was formerly known as Wow Factor Public… Read more
X Bioscience Public Company Limited (XBIO) - Net Assets
Latest net assets as of September 2024: ฿264.02 Million THB
Based on the latest financial reports, X Bioscience Public Company Limited (XBIO) has net assets worth ฿264.02 Million THB as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿808.02 Million) and total liabilities (฿544.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿264.02 Million |
| % of Total Assets | 32.67% |
| Annual Growth Rate | -42.25% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 67.66 |
X Bioscience Public Company Limited - Net Assets Trend (2020–2023)
This chart illustrates how X Bioscience Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for X Bioscience Public Company Limited (2020–2023)
The table below shows the annual net assets of X Bioscience Public Company Limited from 2020 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | ฿182.81 Million | +78.27% |
| 2022-12-31 | ฿102.54 Million | -84.77% |
| 2021-12-31 | ฿673.41 Million | -28.97% |
| 2020-12-31 | ฿948.11 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to X Bioscience Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16285048300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ฿1.30 Billion | 710.65% |
| Total Equity | ฿182.80 Million | 100.00% |
X Bioscience Public Company Limited Competitors by Market Cap
The table below lists competitors of X Bioscience Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Famsa S.A.B. de C.V
MX:GFAMSAA
|
$430.25K |
|
BIJOU BRIGITTE
MU:BIJ
|
$430.31K |
|
COSW
BATS:COSW
|
$430.77K |
|
Puget Technologies Inc
PINK:PUGE
|
$430.87K |
|
LifeX 2030 Income Bucket ETF
BATS:BCKT
|
$429.99K |
|
Intergama
TA:INTR
|
$429.77K |
|
BERKELEY GRP - Dusseldorf Stock Exchang
DU:42BA
|
$429.28K |
|
Hiru Corporation
PINK:HIRU
|
$428.98K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in X Bioscience Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 102,541,379 to 182,803,766, a change of 80,262,387 (78.3%).
- Net loss of 147,521,435 reduced equity.
- New share issuances of 227,783,822 increased equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿-147.52 Million | -80.7% |
| Share Issuances | ฿227.78 Million | +124.61% |
| Total Change | ฿- | 78.27% |
Book Value vs Market Value Analysis
This analysis compares X Bioscience Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.39x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.39x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | ฿17.47 | ฿0.07 | x |
| 2021-12-31 | ฿0.83 | ฿0.07 | x |
| 2022-12-31 | ฿0.13 | ฿0.07 | x |
| 2023-12-31 | ฿0.18 | ฿0.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently X Bioscience Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -80.70%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -47.32%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 4.04x
- Recent ROE (-80.70%) is above the historical average (-176.69%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -25.19% | -57.46% | 0.32x | 1.35x | ฿-333.62 Million |
| 2021 | -41.05% | -108.82% | 0.19x | 1.96x | ฿-343.79 Million |
| 2022 | -559.81% | -166.64% | 0.49x | 6.83x | ฿-584.30 Million |
| 2023 | -80.70% | -47.32% | 0.42x | 4.04x | ฿-165.80 Million |
Industry Comparison
This section compares X Bioscience Public Company Limited's net assets metrics with peer companies in the Food Distribution industry.
Industry Context
- Industry: Food Distribution
- Average net assets among peers: $63,761,103,155
- Average return on equity (ROE) among peers: 10.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| X Bioscience Public Company Limited (XBIO) | ฿264.02 Million | -25.19% | 2.06x | $430.24K |
| CP Axtra Public Company Limited (CPAXT) | $298.62 Billion | 3.54% | 0.83x | $707.11 Million |
| Pluk Phak Praw Rak Mae Public Company Limited (OKJ) | $446.31 Million | 8.59% | 1.25x | $17.53 Million |
| Premier Marketing Public Company Limited (PM) | $1.71 Billion | 21.55% | 0.50x | $67.72 Million |
| Saha Pathanapibul Public Company Limited (SPC) | $17.36 Billion | 10.04% | 0.54x | $134.12 Million |
| Wow Factor PCL (W) | $671.36 Million | 7.80% | 0.05x | $8.89 Million |